搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
The Pharma Letter
23 小时
FDA approves new injectable version of Opdivo
The US Food and Drug Administration (FDA) on Friday approved nivolumab and hyaluronidase-nvhy, under the trade name Opdivo ...
The Pharma Letter
14 小时
Axon Pharma
"A dynamic and versatile pharmaceutical company with regional horizons in Latin America." "Axon Pharma is an independent multinational pharmaceutical company built on high-standards science and ...
The Pharma Letter
14 小时
Set a new password
39-43 Putney High Street, Putney London, SW15 1SP United Kingdom ...
The Pharma Letter
2 天
Second FDA approval for BeiGene’s Tevimbra in 2024
The US Food and Drug Administration (FDA) has approved Tevimbra (tislelizumab-jsgr), in combination with platinum and ...
The Pharma Letter
2 天
Akums in long-term deal to supply oral drugs to Europe
Akums secures a strategic deal to manufacture and supply oral liquid formulations for a global pharma company in Europe. The ...
The Pharma Letter
2 天
Inmagene takes back-door route to Nasdaq listing
Inmagene Biopharmaceuticals merges with Ikena Oncology to form InmageneBio, focusing on IMG-007, an OX40-targeting antibody ...
The Pharma Letter
2 天
AusperBio raises $73 million to advance hepatitis B therapy
AusperBio raises $73 million in series B funding to advance Phase II trials of AHB-137, its antisense oligonucleotide therapy ...
The Pharma Letter
2 天
Mankind Pharma and Innovent partner for sintilimab
Mumbai, India-based Mankind Pharma has entered into a partnership with China’s Innovent Biologics for exclusively licensing ...
The Pharma Letter
2 天
FDA label changes for transmucosal buprenorphine products
The US Food and Drug Administration (FDA) has issued the Federal Register notice, Modifications to Labeling of ...
The Pharma Letter
2 天
Takeda’s Hyqvia approved as first-of-kind immunoglobulin therapy in Japan
The Japanese Ministry of Health, Labor and Welfare (MHLW) has approved the use of Hyqvia (immune globulin infusion 10% [human ...
The Pharma Letter
2 天
Kaken inks license agreement for STAT6 Inhibitor
Japanese drugmaker Kaken Pharmaceutical has entered into a license agreement with US healthcare giant Johnson & Johnson for ...
The Pharma Letter
5 天
FDA approves Lilly drug for obstructive sleep apnea
US pharma major Eli Lilly today announced the US Food and Drug Administration (FDA) approved Zepbound its (tirzepatide) as ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈